Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
RGNXCompany Name
REGENXBIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQREGENXBIO INC - Price to Free Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
RGNX - P/FCF Historical data
| Date | Free Cash Flow | Market Capitalization | Price to Free Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ -90.71M | $ 399.06M | 0 |
| 3/31/2025 | $ -86.94M | $ 399.78M | 0 |
| 12/31/2024 | $ -175.56M | $ 328.06M | 0 |
| 9/30/2024 | $ -184.74M | $ 467.21M | 0 |
| 6/30/2024 | $ -194.72M | $ 657.82M | 0 |
| 3/31/2024 | $ -198.64M | $ 821.1M | 0 |
| 12/31/2023 | $ -228.37M | $ 889.44M | 0 |
| 9/30/2023 | $ -231.32M | $ 721.91M | 0 |
| 6/30/2023 | $ -235.98M | $ 830.85M | 0 |
| 3/31/2023 | $ -257.07M | $ 879.32M | 0 |
Key Performance Insights, Last 5 Years
- REGENXBIO INC's latest trailing twelve months (TTM) P/FCF stands at 0.
- Over the past 5 years, REGENXBIO INC's average P/FCF has been 9.32.
- The median P/FCF for REGENXBIO INC during this period was 8.6
- REGENXBIO INC reached its highest P/FCF over the past 5 years at 12.38.
- The lowest P/FCF recorded by REGENXBIO INC in the same timeframe 7.71
REGENXBIO INC's P/FCF vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/FCF Benchmarks
Similar metrics to P/FCF:
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
Definition of Price to Free Cash Flow
[Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].Market Cap / FCF
(=) P/FCF P/FCF for REGENXBIO INC is calculated as follows: Market Cap [ $ 1.16B ] / FCF [ $ -134.05M ]
(=) P/FCF [ 0 ] RGNX - Price to Free Cash Flow, Last 5 years
7.71
Minimum
Sep 30, 2022
12.38
Maximum
Jun 30, 2022
9.32
Average
8.6
Median
P/FCF Benchmark AnalysisMarket
The chart above depicts the distribution of P/FCF for companies in the Total Stock Market. The average P/FCF of the companies is 18.31 with a standard deviation of 12.92.
The following table provides additional summary stats:
P/FCF in the Market:
| filtered constituents | 2.23K |
|---|---|
| min | 0.06 |
| max | 60.45 |
| average | 18.31 |
| median | 14.73 |
| std | 12.92 |